You are being redirected to the story the piece of content is found in so you can read it in context. Please click the following link if you are not automatically redirected within a couple seconds:
en/glaxo-novo-merck-lead-on-access-to-medicines-according-to-new-ranking#c29536

2008 Index outcomes

Author: Access to Medicine Foundation, Published on: 18 June 2008

This web tool enables visitors to click and sort through the outcomes of the 2008 Access to Medicine Index. The tool presents ratings and rankings of the efforts of twenty of the world’s largest pharmaceutical companies to increase universal access to medicine. Companies can be ranked according to their overall performance or according to scores on one of eight ‘main criteria’...[includes link to full 2008 Access to Medicine Index report]

Read the full post here

Related companies: Abbott Laboratories AstraZeneca Bayer Bristol-Myers Squibb Cipla Eli Lilly Gilead Sciences GlaxoSmithKline Johnson & Johnson Merck Novartis Novo Group Novo Nordisk (part of Novo Group) Pfizer Ranbaxy Laboratories Roche Sanofi Schering-Plough Teva Pharmaceutical Wyeth (part of Pfizer)